Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Hemangioma 6Hemangioma, Capillary 4Multiple Myeloma 2Fallopian Tube Neoplasms 2Breast Neoplasms 2Tuberous Sclerosis 1Prostatic Neoplasms 1Neuroblastoma 1Melanoma 1Hemangiosarcoma 1Hemangioma, Cavernous, Central Nervous System 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

Propranolol 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hemangioma, Cavernous, Central Nervous System × Propranolol × Clear all
NCT03589014 2022-02-25

Treat_CCM

Mario Negri Institute for Pharmacological Research

Phase 2 Completed
71 enrolled
CNS

Hemangioma, Cavernous, Central Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon âš¡